PharmaBlue is a French company, belonging to PharmaLex Group, partnering with Pharmaceutical Companies looking to appoint a local "Exploitant" for the distribution of their medicines on the French market.
PharmaBlue was founded in 2015.
PharmaBlue offers “Exploitant” services to Pharmaceutical Companies looking to distribute their medicines in France.
PharmaBlue holds an “Exploitant” Authorization granted by ANSM.
The Exploitant services include overlooking wholesale distribution, advertising, medical information, pharmacovigilance, batch follow-up and, where necessary, batch recall for pharmaceutical products on the French Market (as described in art R 5124-36 of the French Public Health Code).
PharmaBlue holds a robust Quality Management System (QMS) :
To control and improve its activities
To reach the level of conformity as expected by its clients
To fullfill the French regulatory requirements
This QMS helps us to lead our business in accordance with the current regulations and guidelines in the interest of public health.
Training to Quality documents
Training of new comers / continuous training
Internal and external audits
Management of quality agreements, control of subcontractors, audits, product quality review…
Ensure compliance to Marketing authorizations/ATU, GMP, GDP, planned and unplanned deviations, OOS/OOT…)
Management of quality agreements, control of subcontractors, audits, product quality review…
Management of all changes impacting the quality of the pharmaceutical products and/or processes (including risk analysis)
